Molecular Profiles to launch US strategic alliance at AAPS

4 years ago

Nottingham, UK – Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX) and Maryland-based Xceleron have announced a collaboration to assist drug developers with improved efficiency during clinical development that will be launched at AAPS in San Diego next week. This partnership extends Molecular Profiles’ new ROADMAP to Clinical Trials enabling technologies platform,

Molecular Profiles to launch new development platform at CPhI and AAPS

4 years ago

Nottingham, UK – Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX) is set to unveil the ROADMAP to Clinical Trials platform at the annual CPhI/ICSE Worldwide event in Paris and at AAPS 2014, which aims to support companies with the rapid development of both standard and complex drug products. The new enabling technologies screening platform,

Molecular Profiles strengthens capsule capability

4 years ago

Nottingham, UK – Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX) has expanded its capsule filling capability following significant investment into new equipment at its clinical manufacturing site in the UK. The contract development and manufacturing organisation (CDMO) has purchased a capsule bander, which enables the company to now offer liquid filling

Molecular Profiles strikes alliance with XenoGesis

4 years ago

Nottingham, UK – Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX) and XenoGesis Ltd., have announced a collaboration that will support pharmaceutical and biotech drug developers during the pre-clinical and formulation development stage. Molecular Profiles’ pharmaceutical development services will be supported by XenoGesis’ expertise in preclinical drug metabolism and pharmacokinetics (DMPK) to give

Molecular Profiles strengthens US presence to drive growth

4 years ago

Nottingham, UK – Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX), is set to increase awareness and uptake of its pharmaceutical development services in the North American market following the appointment of a new head of US sales. The development and manufacturing services provider, which has a well-established track record for meeting objectives

Molecular Profiles Expands Technology with GMP Hot Melt Extrusion

4 years ago

Nottingham, UK – Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX) has completed a significant investment into additional equipment as part of a wider project focusing on enabling technologies that facilitate processing of difficult-to-progress molecules. The UK-based pharmaceutical development and manufacturing services provider has invested in GMP hot melt extrusion (HME) technology along with

Molecular Profiles joins leading consortium to drive paediatric formulation development

5 years ago

A collaborative pharmaceutical project involving Molecular Profiles focused on improving the pathway for developing paediatric formulations has been given the go-ahead after successfully securing an innovation grant. The UK-wide consortium, led by Astra Zeneca, received a £660k grant from the UK’s innovation agency, the Technology Strategy Board, to help fund a £1million project aimed at

Molecular Profiles to host industry event

5 years ago

Pharmaceutical development and manufacturing services provider Molecular Profiles is set to host a seminar in the UK focused on overcoming biological barriers in drug development. The UK-based company, a subsidiary of Columbia Laboratories, will launch the New Year by welcoming pharmaceutical executives and scientists from across the globe to the two-day conference that aims to give